三月 2026
- Home
- Aquestive Therapeutics, Inc.
三月 2026的Aquestive Therapeutics, ...市场份额分析
Aquestive Therapeutics offers rewarding career opportunities for colleagues who share in our passion to improve the lives of patients and caregivers.
Aquestive Therapeutics, Inc.(包含公司地区分支机构)
查看更多网站流量和参与度信息- aquestive.com
Aquestive Therapeutics, Inc.收入截至 三月 2026为 25M - 50M
Aquestive Therapeutics, Inc.主要域名产生的收入
3 年中Aquestive Therapeutics, Inc.主要域名的收入
Aquestive Therapeutics, Inc.主要域名的收入
Aquestive Therapeutics, Inc.热门域名的总访问量
了解Aquestive Therapeutics, Inc.市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
Aquestive Therapeutics, Inc.热门域名的平均访问时长
分析Aquestive Therapeutics, Inc.参与度指标。
过去 3 个月的平均访问时长
子公司明细
Aquestive Therapeutics, Inc.热门域名的平均页面浏览量
了解Aquestive Therapeutics, Inc.如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
Aquestive Therapeutics, Inc. 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Bronstein, Gewirtz & Grossman, LLC filed suit against Aquestive Therapeutics, Inc. on Apr 16th '26.NEW YORK, April 16, 2026 (GLOBE NEWSWIRE) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Aquestive Therapeutics, Inc. (NASDAQ: AQST) and certain of its officers.
四月 16, 2026阅读更多
新闻Aquestive Therapeutics, Inc. has issues with securities fraud lawsuit.AQST investors have opportunity to lead Aquestive Therapeutics, Inc. securities fraud lawsuit.
四月 11, 2026阅读更多
新闻Holzer & Holzer, LLC files suit against Aquestive Therapeutics, Inc..Holzer & Holzer, LLC reminds investors of lead plaintiff deadlines in shareholder class action lawsuits against Aquestive Therapeutics, Inc. (AQST), Nektar Therapeutics (NKTR), and Eos Energy Enterprises, Inc. (EOSE).
四月 6, 2026阅读更多
查看 Aquestive Therapeutics, Inc. 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。